Prospective, Cluster-Randomized Trial to Implement the Ottawa Model for Smoking Cessation in Diabetes Education Programs in Ontario, Canada

Reid, Robert D.; Malcolm, Janine; Wooding, Evyanne; Geertsma, A.; Aitken, Debbie; Arbeau, D.; Blanchard, Chris M.; Gagnier, Jo-Anne; Gupta, Anil; Mullen, Kerri-Anne; Oh, Paul; Papadakis, Sophia; Tulloch, Heather; LeBlanc, Allana G.; Wells, George A.; Pipe, Andrew

doi:10.2337/dc17-1809

Cited by 26 publications

(29 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The currently available smoking cessation therapies have been shown to double or even triple the dropout rates in controlled studies [93, 94]. A recent study in patients with DM yielded a smoking cessation rate of 11.1% at 6-months in those undergoing an intensive smoking cessation program [95]. However, according to a survey by Diabetes UK, 64.1% of smokers with DM (64.1%) do not receive any assistance or advice to quit [96]—far too many.…”

Section: Smoking Cessation For People With Diabetesmentioning

confidence: 99%

Smoking and diabetes: dangerous liaisons and confusing relationships

Campagna

Alamo

Pino

et al. 2019

Diabetol Metab Syndr

149

View full text Add to dashboard Cite

The combined harmful effects of cigarette smoking and hyperglycemia can accelerate vascular damage in patients with diabetes who smoke, as is well known. Can smoking cause diabetes? What are the effects of smoking on macro and microvascular complications? Now growing evidence indicates that regular smokers are at risk of developing incident diabetes. Since the prevalence rates of smoking in patients with diabetes are relatively similar to those of the general population, it is essential to address the main modifiable risk factor of smoking to prevent the onset of diabetes and delay the development of its complications. Quitting smoking shows clear benefits in terms of reducing or slowing the risk of cardiovascular morbidity and mortality in people with diabetes. Does quitting smoking decrease the incidence of diabetes and its progression? What are the effects of quitting smoking on complications? The current evidence does not seem to unequivocally suggest a positive role for quitting in patients with diabetes. Quitting smoking has also been shown to have a negative impact on body weight, glycemic control and subsequent increased risk of new-onset diabetes. Moreover, its role on microvascular complications of the disease is unclear. What are the current smoking cessation treatments, and which ones are better for patients with diabetes? Stopping smoking may be of value for diabetes prevention and management of the disease and its macrovascular and microvascular complications. Unfortunately, achieving long-lasting abstinence is not easy and novel approaches for managing these patients are needed. This narrative review examines the evidence on the impact of smoking and smoking cessation in patients with diabetes and particularly in type 2 diabetes mellitus and its complications. In addition, management options and potential future directions will be discussed.

show abstract

Section: Smoking Cessation For People With Diabetesmentioning

confidence: 99%

Smoking and diabetes: dangerous liaisons and confusing relationships

Campagna

Alamo

Pino

et al. 2019

Diabetol Metab Syndr

149

View full text Add to dashboard Cite

show abstract

“…Diabetes education programs offer potential to systematically reach and engage individuals with diabetes in smoking cessation efforts. A cluster randomized trial found statistically significant increases in quit rates and long-term abstinence rates (>6 months) when smoking cessation interventions were offered through diabetes education clinics, regardless of motivation to quit at baseline (255). Complex environmental, social, behavioral, and emotional factors, known as psychosocial factors, influence living with diabetes, both type 1 and type 2, and achieving satisfactory medical outcomes and psychological well-being.…”

Section: Smoking Cessation: Tobacco and E-cigarettesmentioning

confidence: 99%

5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2022

2021

Diabetes Care

225

132

View full text Add to dashboard Cite

The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

show abstract

“…However, a recent study in people with diabetes compared the intensive Ottawa Model for Smoking Cessation programme (OMSC), delivered by specially‐trained diabetes educators, with people given usual advice. ‘Smokers in the OMSC group received counseling, a discount card to partially cover the cost of smoking cessation medication, and follow‐up telephone calls over a 6‐month period.’ Biochemically confirmed smoking cessation at six months in those on the OMSC was 11.1% compared with 2.6% in the control group (odds ratio 3.73; 1.20, 11.58) …”

Section: Stopping Smokingmentioning

confidence: 93%